|
|
Identification |
|
Name |
|
Mipragoside |
|
Synonyms |
|
N-[(1S,2R,3E)-1-[[[O-[N-Acetyl-1-(1-methylethyl)-alpha-neuraminosyl]-(2→3)-O-[O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1→4)]-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]octadecanamide |
 |
|
Molecular Structure |
|
![CAS # 131129-98-1, Mipragoside, N-[(1S,2R,3E)-1-[[[O-[N-Acetyl-1-(1-methylethyl)-alpha-neuraminosyl]-(2→3)-O-[O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1→4)]-O-beta-D-galactopyranosyl-(1→4)-beta-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]octadecanamide](/structures/131129-98-1.gif) |
|
|
Molecular Formula |
|
C76H137N3O31 |
|
Molecular Weight |
|
1588.90 |
|
CAS Registry Number |
|
131129-98-1 |
| |
|
Properties |
|
|
Solubility |
|
Practically insoluble (0.03 g/L) (25 ºC), Calc.* |
|
Density |
|
1.32±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
|
|
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
